玻璃酸钠滴眼液对干眼患者生物测量参数及人工晶状体度数的影响

doi:10.3760/cma.j.cn115909-20210216-00061

摘要
图/表
参考文献(37)
相关文章 (15)

全文: PDF 753KB HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

文章导读

摘要目的：研究玻璃酸钠滴眼液对干眼患者及无干眼者生物测量参数及人工晶状体度数的影响。方法：前瞻性非随机对照研究。纳入2018年8月1日至2019年3月1日于解放军总医院第一医学中心眼科门诊就诊患者140例（140眼），根据干眼检测指标分为中重度干眼组、轻度干眼组和无干眼组，其中中重度干眼组40例，轻度干眼组50例，无干眼组50例，均取其右眼数据。所有患者行IOLMaster 700 生物测量后，滴入1滴0.1%的玻璃酸钠滴眼液，分别于5 min、10 min及15 min后再次行IOLMaster 700生物测量，比较3组滴入玻璃酸钠滴眼液前后不同时间点中央角膜厚度（CCT）、角膜曲率（K）、散光度数（K2-K1）及散光轴位的差异，并分别计算人工晶状体（IOL）度数，采用方差分析或t检验进行数据分析。结果：点药前，与无干眼组相比较，中重度干眼组CCT较小（P=0.030），K1、K2 较大（P=0.048、0.041），IOL度数较小（P=0.018）；轻度干眼组K1、K2较大（P=0.022、0.011），IOL 度数无明显差异。中重度干眼组在滴入1滴玻璃酸钠滴眼液后5 min，CCT及IOL度数有增大的趋势（t=28.244，P<0.001；t=2.623，P=0.012），K1、K2有减小的趋势（t=-0.621，P=0.538；t=-2.462， P=0.018），IOL度数增加0.5 D的眼数占总眼数的18%；10 min后，与点药前比，CCT及IOL度数有增大的趋势（t=7.334，P<0.001；t=4.425，P<0.001），K1、K2有减小的趋势（t=-4.876，P<0.001； t=-4.179，P<0.001），22.5%的IOL度数增大0.5 D或1.0 D。15 min后，IOLMaster测量参数均回到干预前水平。轻度干眼组在滴药后5 min及10 min，与点药前比较除CCT增大（t=9.286，P<0.001； t=7.516，P<0.001），余生物测量参数差异均无统计学意义；点药后15 min，所有生物测量参数较点药前差异均无统计学意义。无干眼组在滴后5 min及10 min，CCT有增大趋势（t=11.618，P<0.001； t=16.785，P<0.001），IOL度数有减小的趋势（t=-2.641，P=0.011；t=-1.429，P=0.159），IOL度数最大减小0.5 D；15 min后，所有生物测量参数较点药前差异均无统计学意义。各时间点中重度干眼组角膜前表面散光轴位变化较其他2组大，滴后5 min，3组差异有统计学意义（F=3.220，P=0.043）。结论：玻璃酸钠滴眼液的使用可能改变生物测量的数据，尤其对于合并有中重度干眼的患者。滴入玻璃酸钠滴眼液后短时间内，角膜曲率及散光轴位发生变化，中重度干眼患者IOL预测值增大、无干眼患者IOL预测值减小。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ： , 干眼, 人工泪液, 白内障, IOLMaster, 人工晶状体度数

Abstract： Objective: To assess the changes in measurement parameters and intraocular lens power after instillation of sodium hyaluronate eye drops in dry eye patients and non-dry eye patients. Methods: Non-randomized controlled clinical research was performed. Patients with moderate to severe dry eye (40 eyes), mild dry eye (50 eyes) and non-dry eye (50 eyes) were included in this study. All patients underwent IOL Master 700 bioassay before and 5 min, 10 min and 15 min after instilling 0.1% sodium hyaluronate eye drops. Differences in central corneal thickness (CCT), corneal curvature (K), astigmatism (K2-K1), axis position and intraocular lens (IOL) power were compared before and after instillation of a drop of sodium hyaluronate. Results: Before instilling sodium hyaluronate eye drops, compare with non-dry eye group, CCT was thicker (P=0.30), K1 and K2 was higher (P=0.048, 0.041), IOL was smaller in moderate to severe dry eye group (P=0.018); and K1 and K2 was higher in mild dry eye group (P=0.022, 0.011). For the moderate to severe dry eye group, CCT and IOL power increased at 5 min and 10 min after instilling sodium hyaluronate eye drops (CCT: t=28.244, P<0.001; t=7.334, P<0.001; IOL: t=2.623, P=0.012; t=4.425, P<0.001), and K showed a decreasing trend (K1: t=-0.621, P=0.538; t=-4.876, P<0.001; K2: t=-2.462, P=0.018; t=-4.179, P<0.001). Five minutes after instilling sodium hyaluronate eye drops, IOL power in 17.5% of the cases increased by 0.5 D. Further, IOL power in 22.5% of the cases increased by 0.5 D or 1.0 D in 10 minutes. After 15 minutes, the IOLMaster parameters returned to the level of pre-intervention. For the non-dry eye group, CCT increased 5 and 10 minutes after instilling sodium hyaluronate eye drops (t=11.618, P<0.001; t=16.785, P<0.001), and the IOL power decreased by a maximum of 0.5 D (t=-2.641, P=0.011; t=-1.429, P=0.159). After 15 min, there was no significant difference for any parameters. The axial position of astigmatism on the anterior corneal surface of the moderate to severe dry eye group changed significantly in 5 min (F=3.220, P=0.043). Conclusions: For patients with moderate to severe dry eyes or non-dry eyes, sodium hyaluronate eye drops may alter biometric measurements, leading to changes in IOL predicted values.

Key words： dry eye artificial tear cataract IOLMaster intraocular lens power

收稿日期: 2021-02-16

PACS:

基金资助: 国家自然科学基金（81870640、81670838）；北京市自然科学基金（7182152）；解放军总医院临床扶持基金（2017FC-ZHCG-3003）

通讯作者: 李朝辉（ORCID：0000-0003-2030-504X），Email：13701239057@163.com

引用本文:

李景兰叶子马天驹高艺杨青华李朝辉. 玻璃酸钠滴眼液对干眼患者生物测量参数及人工晶状体度数的影响[J]. 中华眼视光学与视觉科学杂志, 2021, 23(7): 491-499. Jinglan Li, Zi Ye, Tianju Ma, Yi Gao, Qinghua Yang, Zhaohui Li. Effect of Sodium Hyaluronate Eye Drops on Measurement Parameters and Intraocular Lens Power in Dry Eye Patients. Chinese Journal of Optometry Ophthalmology and Visual science, 2021, 23(7): 491-499. DOI: 10.3760/cma.j.cn115909-20210216-00061

链接本文:

https://www.cjoovs.com/CN/10.3760/cma.j.cn115909-20210216-00061 或 https://www.cjoovs.com/CN/Y2021/V23/I7/491

[1]	Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocul Surf, 2017, 15(3): 334-365. DOI: 10.1016/j.jtos.2017.05.003.
[2]	晏晓明. 解读国际泪膜与眼表协会2017年干眼专家共识中的干眼流行病学. 中华实验眼科杂志, 2019, 37(3): 226-228. DOI: 10.3760/cma.j.issn.2095-0160.2019.03.013.
[3]	Song P, Xia W, Wang M, et al. Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: A systematic review and meta-analysis. J Glob Health, 2018, 8(2): 020503. DOI: 10.7189/jogh.08.020503.
[4]	Liu NN, Liu L, Li J, et al. Prevalence of and risk factors for dry eye symptom in mainland china: A systematic review and meta-analysis. J Ophthalmol, 2014, 2014: 748654. DOI: 10.1155/2014/748654.
[5]	Wozniak PA, Schmidl D, Bata AM, et al. Effect of different lubricant eye gels on tear film thickness as measured with ultrahigh-resolution optical coherence tomography. Acta Ophthalmol, 2017, 95(4): e307-307e313. DOI: 10.1111/ aos.13342.
[6]	李朝辉, 李景兰, 叶子. 解读《2017年APACRS白内障手术临床实践指南》. 中华实验眼科杂志, 2019, 37(4): 301-303. DOI: 10.3760/cma.j.issn.2095-0160.2019.04.013.
[7]	Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol, 2000, 118: 615-21.
[8]	Amparo F, Schaumberg DA, Dana R. Comparison of twoquestionnaires for dry eye symptom assessment: The ocular surface disease index and the symptom assessment in dry eye. Ophthalmology, 2015, 122(7): 1498-1503. DOI: 10.1016/ j.ophtha.2015.02.037.
[9]	Nelson JD, Craig JP, Akpek EK, et al. TFOS DEWS II Introduction. Ocul Surf, 2017, 15(3): 269-275. DOI: 10.1016/ j.jtos.2017.05.005.
[10]	Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf, 2017, 15(3): 276-283. DOI: 10.1016/j.jtos.2017.05.008.
[11]	Bartlett JD, Keith MS, Sudharshan L, et al. Associations between signs and symptoms of dry eye disease: A systematic review. Clin Ophthalmol, 2015, 9: 1719-1730. DOI: 10.2147/ OPTH.S89700.
[12]	Pekel E, Pekel G. Clinical characteristics of dry eye patients with chronic pain syndromes. Am J Ophthalmol, 2016, 166: 203. DOI: 10.1016/j.ajo.2016.03.022.
[13]	Vehof J, Sillevis Smitt-Kamminga N, Nibourg SA, et al. Predictors of discordance between symptoms and signs in dry eye disease. Ophthalmology, 2017, 124(3): 280-286. DOI: 10.1016/j.ophtha.2016.11.008.
[14]	Caffery B, Harthan J, Srinivasan S, et al. Sjogren's syndrome in optometric practices in North America. Cont Lens Anterior Eye, 2018, 41(6): 518-526. DOI: 10.1016/j.clae.2018.08.006.
[15]	Koh S. Mechanisms of visual disturbance in dry eye. Cornea, 2016, 35 Suppl 1: S83-83S88. DOI: 10.1097/ ICO.0000000000000998.
[16]	Koh S. Irregular astigmatism and higher-order aberrations in eyes with dry eye disease. Invest Ophthalmol Vis Sci, 2018, 59(14): DES36-DES40. DOI: 10.1167/iovs.17-23500.
[17]	Koh S, Tung CI, Inoue Y, et al. Effects of tear film dynamics on quality of vision. Br J Ophthalmol, 2018, 102(12): 1615-1620. DOI: 10.1136/bjophthalmol-2018-312333.
[18]	Deinema LA, Vingrys AJ, Chinnery HR, et al. Optical coherence tomography reveals changes to corneal reflectivity and thickness in individuals with tear hyperosmolarity. Transl Vis Sci Technol, 2017, 6(3): 6. DOI: 10.1167/tvst.6.3.6.
[19]	Sanchis-Gimeno JA, Lleó-Pérez A, Alonso L, et al. Reduced corneal thickness values in postmenopausal women with dry eye. Cornea, 2005, 24(1): 39-44. DOI: 10.1097/01. ico.0000138836.45070.0f.
[20]	Liu Z, Pflugfelder SC. Corneal thickness is reduced in dry eye. Cornea, 1999, 18(4): 403-407. DOI: 10.2147/OPTH.S119343.
[21]	Akyol-Salman I, Azizi S, Mumcu U, et al. Central corneal thickness in patients with meibomian gland dysfunction. Clin Exp Optom, 2011, 94(5): 464-467. DOI: 10.1111/j.1444- 0938.2011.00631.x.
[22]	兰长骏, 彭悦, 廖萱. 扫频光相干断层扫描生物测量仪在白内障中的应用. 中华实验眼科杂志, 2019, 37(2): 123-128. DOI: 10.3760/cma.j.issn.2095-0160.2019.02.010.
[23]	Gupta PK, Drinkwater OJ, VanDusen KW, et al. Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation. J Cataract Refract Surg, 2018, 44(9): 1090- 1096. DOI: 10.1016/j.jcrs.2018.06.026.
[24]	Labetoulle M, Rousseau A, Baudouin C. Management of dry eye disease to optimize cataract surgery outcomes: Two tables for a daily clinical practice. J Fr Ophtalmol, 2019, 42(8): 907- 912. DOI: 10.1016/j.jfo.2019.03.032.
[25]	Villani E, Marelli L, Bonsignore F, et al. The ocular surface frailty index as a predictor of ocular surface symptom onset after cataract surgery. Ophthalmology, 2020, 127(7): 866-873. DOI: 10.1016/j.ophtha.2019.12.012.
[26]	Shajari M, Kolb CM, Petermann K, et al. Comparison of 9 modern intraocular lens power calculation formulas for a quadrifocal intraocular lens. J Cataract Refract Surg, 2018, 44(8): 942-948. DOI: 10.1016/j.jcrs.2018.05.021.
[27]	Melles RB, Holladay JT, Chang WJ. Accuracy of intraocular lens calculation formulas. Ophthalmology, 2018, 125(2): 169- 178. DOI: 10.1016/j.ophtha.2017.08.027.
[28]	Afsharkhamseh N, Movahedan A, Motahari H, et al. Cataract surgery in patients with ocular surface disease: An update in clinical diagnosis and treatment. Saudi J Ophthalmol, 2014, 28(3): 164-167. DOI: 10.1016/j.sjopt.2014.06.013.
[29]	Epitropoulos AT, Matossian C, Berdy GJ, et al. Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning. J Cataract Refract Surg, 2015, 41(8): 1672-1677. DOI: 10.1016/j.jcrs.2015.01.016.
[30]	Asbell P, Vingrys AJ, Tan J, et al. Clinical outcomes of fixed versus as-needed use of artificial tears in dry eye disease: A 6-week, observer-masked phase 4 clinical trial. Invest Ophthalmol Vis Sci, 2018, 59(6): 2275-2280. DOI: 10.1167/ iovs.17-23733.
[31]	Wang TJ, Wang IJ, Ho JD, et al. Comparison of the clinical effects ofcarbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: A 4-week, prospective, open-label, randomized, parallel-group, noninferiority study. Clin Ther, 2010, 32(1): 44-52. DOI: 10.1016/j.clinthera.2010.01.024.
[32]	Lu N, Lin F, Huang Z, et al. Changes of corneal wavefront aberrations in dry eye patients after treatment with artificial lubricant drops. J Ophthalmol, 2016, 2016: 1342056. DOI: 10.1155/2016/1342056.
[33]	Vandermeer G, Chamy Y, Pisella PJ. Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study. J Fr Ophtalmol, 2018, 41(2): e51-51e57. DOI: 10.1016/ j.jfo.2017.12.001.
[34]	洪莲花, 李英俊. 干眼对年龄相关性白内障患者人工晶体度数测量和计算准确性的影响. 中华实验眼科杂志, 2016, 34(2): 170-174. DOI: 10.3760/cma.j.issn.2095-0160.2016.02.016.
[35]	Çak?r B, Do?an E, Çelik E, et al. Effects of artificial tear treatment on corneal epithelial thickness and corneal topography findings in dry eye patients. J Fr Ophtalmol, 2018, 41(5): 407- 411. DOI: 10.1016/j.jfo.2017.06.032.
[36]	Schmidl D, Schmetterer L, Witkowska KJ, et al. Tear film thickness after treatment with artificial tears in patients with moderate dry eye disease. Cornea, 2015, 34(4): 421-426. DOI: 10.1097/ICO.0000000000000358.
[37]	Tung CI, Kottaiyan R, Koh S, et al. Noninvasive, objective, multimodal tear dynamics evaluation of 5 over-the-counter tear drops in a randomized controlled trial. Cornea, 2012, 31(2): 108-114. DOI: 10.1097/ICO.0b013e31821ea667.